Stryker announces Allan Golston will retire from Board of Directors
Stryker (NYSE:SYK) announced that Allan Golston will not seek re-election at the company's 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025. Golston served on Stryker's Board of Directors for 14 years since 2011, including roles as independent Lead Director (2016-2022), and positions on the Governance and Nominating Committee, while also chairing the Compensation and Human Capital and Audit Committees.
Golston, who has been President of the United States Program at the Bill & Melinda Gates Foundation since 2006, brought extensive healthcare industry experience to Stryker's board. His background includes positions as a certified public accountant and hospital finance executive. He also serves as a director at Harley-Davidson.
Stryker (NYSE:SYK) ha annunciato che Allan Golston non si ricandiderà per il Consiglio di Amministrazione durante l'Assemblea Annuale degli Azionisti del 2025, prevista per l'8 maggio 2025. Golston è stato membro del Consiglio di Amministrazione di Stryker per 14 anni dal 2011, ricoprendo ruoli come Direttore Indipendente (2016-2022) e posizioni nel Comitato di Governance e Nominamenti, oltre a presiedere i Comitati di Compensazione e Risorse Umane e di Audit.
Golston, che dal 2006 è Presidente del Programma degli Stati Uniti presso la Bill & Melinda Gates Foundation, ha portato un'ampia esperienza nel settore della salute nel consiglio di Stryker. Il suo background comprende posizioni come commercialista autorizzato e dirigente finanziario di ospedale. È anche direttore di Harley-Davidson.
Stryker (NYSE:SYK) anunció que Allan Golston no buscará la reelección en la Reunión Anual de Accionistas de la compañía programada para el 8 de mayo de 2025. Golston ha servido en la Junta Directiva de Stryker durante 14 años desde 2011, ocupando roles como Director Principal Independiente (2016-2022) y posiciones en el Comité de Gobernanza y Nominaciones, además de presidir los Comités de Compensación, Capital Humano y Auditoría.
Golston, quien ha sido Presidente del Programa de Estados Unidos en la Fundación Bill y Melinda Gates desde 2006, aportó una amplia experiencia en la industria de la salud a la junta de Stryker. Su trayectoria incluye puestos como contador público certificado y ejecutivo financiero de hospitales. También es director en Harley-Davidson.
스트라이커 (NYSE:SYK)는 앨런 골스턴이 2025년 5월 8일로 예정된 회사의 주주 총회에서 재선에 나서지 않겠다고 발표했습니다. 골스턴은 2011년부터 14년 동안 스트라이커의 이사회에서 활동하였으며, 독립 리드 이사(2016-2022) 역할과 거버넌스 및 지명 위원회의 여러 직책을 수행하였으며, 보상 및 인적 자원 및 감사 위원회를 의장으로 맡았습니다.
골스턴은 2006년부터 빌 및 멜린다 게이츠 재단의 미국 프로그램 회장으로 활동하면서, 스트라이커 이사회에 폭넓은 의료 산업 경험을 가져왔습니다. 그의 배경에는 공인 회계사 및 병원 재무 임원으로의 경력이 포함됩니다. 그는 또한 하리데이비슨의 이사로도 활동하고 있습니다.
Stryker (NYSE:SYK) a annoncé que Allan Golston ne sollicitera pas sa réélection lors de l'Assemblée Générale Annuelle des Actionnaires de l'entreprise prévue le 8 mai 2025. Golston a siégé au Conseil d'Administration de Stryker pendant 14 ans, depuis 2011, occupant des rôles tels que Directeur Principal Indépendant (2016-2022) et siégeant au Comité de Gouvernance et de Nominations, tout en présidant les Comités de Rémunération, de Capital Humain et d'Audit.
Golston, qui est Président du Programme États-Unis à la Fondation Bill & Melinda Gates depuis 2006, a apporté une vaste expérience dans l'industrie de la santé au conseil de Stryker. Son parcours professionnel comprend des postes de comptable agréé et de dirigeant financier d'hôpital. Il est également administrateur chez Harley-Davidson.
Stryker (NYSE:SYK) gab bekannt, dass Allan Golston bei der Hauptversammlung der Aktionäre des Unternehmens 2025, die für den 8. Mai 2025 angesetzt ist, nicht zur Wiederwahl antreten wird. Golston war seit 2011 14 Jahre lang im Vorstand von Stryker tätig, darunter als unabhängiger Lead-Direktor (2016-2022) und in verschiedenen Positionen im Governance- und Nominierungsausschuss, während er auch den Ausschuss für Vergütung und Humanressourcen sowie den Prüfungsausschuss leitete.
Golston, der seit 2006 Präsident des USA-Programms der Bill & Melinda Gates Foundation ist, brachte umfassende Erfahrung aus der Gesundheitsbranche in den Vorstand von Stryker ein. Sein beruflicher Werdegang umfasst Positionen als Wirtschaftsprüfer und Finanzleiter in Krankenhäusern. Er ist auch Direktor bei Harley-Davidson.
- None.
- None.
Portage, Michigan, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 14 years of distinguished service, Allan Golston has notified the company that he will not stand for re-election at Stryker's 2025 Annual Meeting of Shareholders, which is expected to be held on May 8, 2025.
Golston joined Stryker’s Board of Directors in 2011 and served as independent Lead Director from 2016 to 2022. He also served on the Governance and Nominating Committee and as Chair of the Compensation and Human Capital and Audit Committees.
“We are grateful for Allan’s many contributions to the board over the years and thank him for his strategic guidance and steadfast support of our growth ambitions,” said Kevin Lobo, Chair and Chief Executive Officer, Stryker. “We thank Allan for his leadership and dedication in helping Stryker advance our mission of making healthcare better.”
Golston has served as the President, United States Program for the Bill & Melinda Gates Foundation since 2006, and as Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. He is also a director of Harley-Davidson, Inc., a manufacturer of motorcycles and accessories. Golston has extensive experience in auditing, finance and the healthcare industry. He is a certified public accountant and has held hospital finance executive positions. In his service to the Gates Foundation, he has contributed to the strategic formation and operation of successful initiatives to provide healthcare, education and other human needs, all of which gave him an understanding that assisted Stryker in its global efforts to meet the needs of patients and caregivers.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries please contact:
Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or jason.beach@stryker.com
For media inquiries please contact:
Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com
FAQ
When will Allan Golston leave Stryker's (SYK) Board of Directors?
What positions did Allan Golston hold on Stryker's (SYK) Board?
How long did Allan Golston serve on Stryker's (SYK) Board of Directors?
What is Allan Golston's current role outside of Stryker (SYK)?
